Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT2014102919037N2
IRCT2014102919037N2
Completed
Phase 2

Evaluation of the Effect of Betamethasone on Neonatal Outcomes in Late Preterm Pregnancies

Investigator0 sites140 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCondition 1: Respiratory Distress Syndrome of Newborn. Condition 2: Preterm Labour and Delivery.Hyaline Membrane DiseaseOnset (Spontaneous) of Labour Before 37 Completed Weeks of Gestation

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Respiratory Distress Syndrome of Newborn. Condition 2: Preterm Labour and Delivery.
Sponsor
Investigator
Enrollment
140
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Investigator

Eligibility Criteria

Inclusion Criteria

  • •Pregnant women aged between 18 to 39 years who are candidate for delivery in 34\-36th week of gestational age
  • •Exclusion criteria:
  • •Delivery after 37th week of gestational age; diabetes; fetal anomalies; delivery before receiving the two doses of the drug; multiple pregnancy

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effect of steroid on neonatal respiratory morbidity in elective cesarean section in 37 weeks or laterRespiratory distress syndrome of newborn.Respiratory distress syndrome of newborn
IRCT20120918010876N4Shahid Beheshti University of Medical Sciences220
Completed
Phase 2
Assessment of efficacy of antenatal betamethasone on neonatal respiratory outcome of late preterm delivery (34-37 weeks)Respiratory distress syndrome of newborn.Respiratory distress syndrome of newborn
IRCT20120918010876N3Shahid Beheshti University of Medical Sciences- Mahdieh Hospital200
Completed
Not Applicable
Evaluation of the administration of betamethasone on late preterm labor and its outcomes.Condition 1: Neonatal respiratory distress syndrome. Condition 2: Preterm Labor.Hyaline Membrane DiseaseOnset (Spontaneous) of Labor Before 37 Completed Weeks of Gestation
IRCT2014050217365N2rmia University of Medical Sciences200
Recruiting
Phase 3
The effect of betamethasone injection in pregnant women exposed to preterm laborPreterm labor.
IRCT20191202045571N1Gorgan University of Medical Sciences110
Not yet recruiting
Phase 1
Betamethasone mouthwash in the treatment of patients with oral lichen planuslichen planus.Lichen planus
IRCT20240804062631N1Kerman University of Medical Sciences56